CD38 and Miyoshi myopathy: explored various CD38/CD47 BsAbs, each with unique in vitro properties: IMM5605–26B4 displayed the most potent inhibitory effect on CD38 enzymatic activity, while IMM5605–12C10 was effective in directly killing MM cells and completely eradicating established tumors in mouse models (69).